A comprehensive view of new use. This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

HID Global acquires GuardRFID, a provider of real-time location services hardware, software solutions in healthcare space; acquisition includes active RFID tags, readers, exciters, software support for patient, staff safety
Published: February 08, 2023 by HID Global Corp.
AstraZeneca and MSD’s Lynparza tablets combined with abiraterone and prednisone or prednisolone now approved in the EU for treatment of metastatic castration-resistant prostate cancer
Published: December 21, 2022 by AstraZeneca AB
GSK updates prescribing information for the ovarian cancer drug Zejula, limiting use to second-line maintenance therapy only to patients with certain mutation types; change was made at the request of FDA following review of Phase 3 clinical results
Published: November 14, 2022 by PharmaBiz (India)
Army’s testbed ISR business jets are opening doors to new mission possibilities
Published: September 06, 2022 by Breaking Defense
Moderna completes submission to the FDA requesting emergency use authorization for Omicron-targeting bivalent COVID-19 booster vaccine; application is for a booster dose in adults age 18 years and older
Published: August 26, 2022 by Moderna Inc.

Ask us about our R&D/Patents market view

Trending Chart

Interactive chart with headline count